Latigo Biotherapeutics
LTGO · NASDAQ
$15.02−$1.55 (−9.35%)TodayMarket closed ·
Prev close $16.57
Who owns LTGO
Largest institutional holders, from their latest 13F filings
The 8 largest institutions hold 80.3% of LTGO’s shares.
- 5AM Ventures22.1%
- Westlake Village BioPartners19.9%
- Foresite Capital Management, LLC13.8%
- RA Capital Management, LP8.0%
- Next 4 largest institutions16.4%
- All other shareholders19.7%
| Holder | Shares | % of shares |
|---|---|---|
| 5AM Ventures | 14.65M | 22.10% |
| Westlake Village BioPartners | 13.20M | 19.91% |
| Foresite Capital Management, LLC | 9.18M | 13.85% |
| RA Capital Management, LP | 5.30M | 7.99% |
| Deep Track Capital LP | 4.45M | 6.71% |
| Access Industries, Inc. | 3.19M | 4.80% |
| Blue Owl Capital Inc. | 3.15M | 4.75% |
| Farzan (Nima) | 114.45K | 0.17% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $5.04M (2 trades) of LTGO on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Foresite Capital Management V, LLC | Other | 195.78K | — |
| Foresite Capital Management V, LLC | Other | 296.88K | — |
| Foresite Capital Management V, LLC | Other | 3.12M | — |
| Foresite Capital Management V, LLC | Other | 742.20K | — |
| Foresite Capital Management V, LLC | Other | 1.13M | — |
| Foresite Capital Management V, LLC | Other | 445.32K | — |
| Foresite Capital Management V, LLC | Other | 3.12M | — |
| Foresite Capital Management V, LLC | Other | 296.88K | — |
| Foresite Capital Management V, LLC | Other | 3.12M | — |
| Foresite Capital Management V, LLC | Other | 195.78K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 832.09K
- Days to cover
- 1.60
- % of shares outstanding
- 1.26%
- Average daily volume
- 519.46K
- Change since last report
- +84.9%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.